Digital consumption all around the globe is skyrocketing, and web experiences are becoming more interactive, thus the ...

SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) today reported that ...

CoreStack today announced the release of a major new, agentic, AI-powered version of its multi-cloud Assessments platform, ...

A practical and up-to-date roadmap to securing cloud containers on AWS, GCP, and Azure can be downloaded for free for a ...

Voting will take place Tuesday evening from 4 p.m. until 9 p.m. at the Garden City Park Water District located at 333 Marcus ...

MRD-negative response rate in four patients; all remain in response through the longest follow up of 5 monthsFavorable ...

CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of prostaglandin-mediated inflammation announced today that data from two of its ...

Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that it has closed a non-brokered private placement (the "Offering") ...

UK researchers have reported early evidence that a new vaccine could provide better protection against whooping cough ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been ...

Amgen today announced that its Board of Directors declared a $2.52 per share dividend for the first quarter of 2026. The dividend will be paid on March 6, 2026, to all stockholders of record as of the ...

Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,262% of patients treated with ...